Quibim
Medical imaging transformed into actionable predictions
Quibim is a portfolio company of APEX Ventures, specializing in AI models for medical imaging. The company raised $50 million in Series A funding in 2025.
How We Help
Problem Statement
The challenge of efficiently and accurately extracting quantitative information from medical images to aid in disease detection, diagnosis, and treatment monitoring.
Core Technology
AI models for medical imaging
Key Differentiators
Provides AI-powered solutions to extract quantitative information from medical images for disease detection, diagnosis, and treatment monitoring.; Transforms medical images into actionable insights.; Offers a QIB platform with a suite of AI models for analyzing various medical image modalities and body regions.; Delivers quantitative biomarkers to enhance diagnostic accuracy and facilitate drug development for diseases such as prostate cancer, Alzheimer's, and multiple sclerosis.
Clinical Focus
Prostate; Brain; Liver; Medical Imaging
Company Info
- Business Model
- SaaS
- Total Funding
- 50,000,000
- Website
- www.quibim.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
FDA 510(k) cleared: QP-Prostate (lesion detection/diagnosis, March 2025), QP-Brain. Mass General Brigham validation study met superiority endpoint for aided radiologist performance. 350+ peer-reviewed publications including prospective multi-centric trials (4000+ patients for prostate cancer aggressiveness prediction). CE/UKCA/TGA/FDA clearances across product line.
MedStartr Index Score
?What do you think of Quibim?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.